Contact us : Support@bioworlde.com
首页 > 产品 > 抗原-多肽
NACAD Peptide BS5814P
Product NameNACAD Peptide
Catalog No.BS5814P
ApplicationsBlocking
Swiss-ProtO15069
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide NACAD. (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS5814 NACAD pAb.
浏览类似产品>>
Size Price
1mg $2680
Product Name :
NACAD Peptide
Applications :
Blocking
Background :
NACAD (NAC alpha domain containing) is a 1,562 amino acid protein that prevents non-secretory polypeptides from targeting the endoplasmic reticulum. Localizing to both the cytoplasm and nucleus, NACAD belongs to the NAC-alpha family and contains one NAC-A/B (NAC-alpha/beta) domain. The gene encoding NACAD maps to human chromosome 7, which houses over 1,000 genes and comprises nearly 5% of the human genome. Chromosome 7 has been linked to Osteogenesis imperfecta, Pendred syndrome, Lissencephaly, Citrullinemia and Shwachman-Diamond syndrome. The deletion of a portion of the q arm of chromosome 7 is associated with Williams-Beuren syndrome, a condition characterized by mild mental retardation, an unusual comfort and friendliness with strangers and an elfin appearance. Deletions of portions of the q arm of chromosome 7 are also seen in a number of myeloid disorders including cases of acute myelogenous leukemia and myelodysplasia.
Alternative Name :
NAC-alpha domain-containing protein 1; KIAA0363
Swiss-Prot :
O15069
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide NACAD. (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS5814 NACAD pAb.
Blocking peptide available as BS5814PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER